Medicamentos de actualidad = Drugs of today

• 

  Año 2017, Vol. 53, Número 12

  • MONOGRAPHS

    • Benralizumab for the treatment of asthma.

      Maria Gabriella Matera, Paola Rogliani, L Calzetta, G.W. Canonica, Mario Cazzola

      • Resumen

      págs. 633-646

      

    • Durvalumab for the treatment of urothelial carcinoma.

      M Alsharedi, R. Srivastava, N Elmsherghi

      • Resumen

      págs. 647-653

      

    • Inotuzumab ozogamicin for the treatment of patients with acute lymphocytic leukemia.

      Aditi Choudhry, S.M. O'Brien

      • Resumen

      págs. 654-666

      

  • MEETING REPORT

    • European Society of Cardiology Congress 2017 (August 26-30, 2017 – Barcelona, Spain).

      S Klischies

      • Resumen

      págs. 667-670

      

  • NEW PRODUCT INTROS

    • New product intros (benralizumab, dinutuximab beta, emicizumab-kxwh, evolocumab (new indication), latanoprostene bunod, mepolizumab (new indication), tofacitinib citrate (new indication), umeclidinium bromide/vilanterol trifenate/fluticasone furoate (new combination).

      págs. 671-674

      

  • CUMULATIVE INDEX

    • Cumulative Index

      págs. 675-707